bacteriemia: An infectious disease caused by bacteria causing sepsis.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
213 |
4. Check minimum number of eventsNone |
213 |
5. Include endpointsNone |
213 |
6. Filter based on genotype QC (FinnGen only) |
213 |
Control definitions (FinnGen only)
- Control exclude
- P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P3
- Name in latin
- Sepsis bacterialis neonatorum
Similar endpoints
↥List of similar endpoints to
Bacterial sepsis of newborn
based on the number of shared cases.
Similar with more cases:
- Infections specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26986 | 11234 | 15752 |
| Only index persons | 10206 | 4214 | 5992 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.39 | 0.32 | 0.44 |
| Only index persons | 0.20 | 0.15 | 0.23 |
| Median age at first event (years) | |||
| Whole population | - | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 213 | 124 | 89 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 185
- Matched controls
- 1850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
+∞
159.2
129
*
P36.0
ICD-10 Finland
Sepsis of newborn due to streptococcus, group B
+∞
21.2
20
*
P36.99
ICD-10 Finland
Bacterial sepsis of newborn, unspecified
+∞
20.2
19
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
7.7
18.0
44
72
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
18.6
11.4
17
10
P07.3
ICD-10 Finland
Other preterm infants
5.4
10.7
33
72
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
+∞
10.5
10
*
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
+∞
7.3
7
*
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
12.9
6.7
11
9
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
14
41
3.58
4.26
4.0
4.5
umol/l
27.9
22.3
0.88
14
41
(3001186) Copper [Moles/volume] in Serum or Plasma
6
7
8.77
3.28
1.2
1.0
umol/l
17.6
21.9
—
6
7
(3020891) Body temperature
11
34
3.35
3.10
3.7
6.7
—
—
—
0
0
(3019225) pH of Specimen
15
57
2.75
3.03
1.9
3.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
16
4.48
2.49
1.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
12
5.10
2.41
1.2
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
12
5.10
2.41
1.2
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
13
4.71
2.28
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
44
288
1.66
2.21
5.9
4.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
51
355
1.57
2.00
4.0
4.3
e6/l
4.5
2.6
0.29
25
212
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
63
461
1.52
1.97
3.5
3.6
mg/l
2.7
2.6
0.03
58
409
(3005719) IgG [Mass/volume] in Serum or Plasma
33
211
1.67
1.81
3.4
5.0
g/l
7.8
8.7
0.59
33
203
(3009508) Creatinine [Moles/volume] in Urine
55
398
1.51
1.80
3.3
5.3
mmol/l
8.1
8.4
0.14
55
375
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
49
349
1.52
1.73
4.2
4.1
e6/l
0.3
0.7
1.57
23
205
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
403
1.49
1.70
3.9
3.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
31
2.64
1.67
1.6
2.4
umol/l
12.1
12.1
—
8
31
(4034850)
6
19
3.21
1.67
8.5
5.6
—
—
—
0
0
(3002256) Pathology report gross observation
19
106
1.87
1.64
1.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
43
0.00
1.54
0.0
3.6
—
3.4
—
0
43
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
15
3.38
1.53
1.4
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
22
132
1.74
1.52
2.7
3.9
mg/l
41.9
131.8
1.00
17
112
(40761535) Cells panel - Urine sediment
13
65
2.06
1.52
4.5
3.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
66
2.03
1.46
3.1
4.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
29
191
1.60
1.44
1.6
1.3
nmol/l
18.5
18.8
0.04
24
165
(3000494) Fungus identified in Specimen by Culture
22
135
1.70
1.42
1.7
2.3
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
7
29
2.46
1.40
5.1
8.4
mg/l
2.3
1.6
—
7
23
(40768446) Kidney Pathology biopsy report
7
29
2.46
1.40
2.6
2.6
—
—
—
0
0
(4035726)
15
82
1.89
1.39
2.1
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
82
1.89
1.39
2.5
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
23
2.65
1.37
1.0
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
67
532
1.38
1.32
8.3
9.5
umol/l
25.8
26.7
0.05
61
486
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
187
1.57
1.32
2.9
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
21
131
1.67
1.29
3.0
4.5
mg/mmol
0.5
12.1
1.80
16
111
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
108
1.73
1.26
2.8
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
28
189
1.55
1.26
2.6
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
52
399
1.40
1.25
11.2
10.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
5
19
2.67
1.22
1.6
2.4
umol/l
0.9
1.1
—
5
19
(3000991) Gas panel - Venous blood
53
410
1.39
1.21
9.7
11.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
47
358
1.40
1.18
4.6
3.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
27
184
1.53
1.17
5.3
4.9
e9/l
64.4
60.3
0.22
20
113
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
39
2.09
1.16
1.6
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
20
2.53
1.15
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
20
2.53
1.15
1.4
1.5
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
20
2.53
1.15
9.6
7.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
32
228
1.47
1.14
2.9
2.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
21
2.41
1.09
2.0
2.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
32
2.22
1.09
2.3
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
32
2.22
1.09
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
45
2.04
1.06
2.6
6.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
22
2.30
1.04
1.2
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
53
1.93
1.03
2.5
1.8
—
—
—
0
0
(44790048)
12
68
1.81
1.02
2.8
2.4
—
—
—
0
0
(44806118)
12
68
1.81
1.02
2.8
2.4
—
—
—
0
0
(44790047)
12
68
1.81
1.02
2.8
2.4
—
—
—
0
0
(44790049)
12
68
1.81
1.02
2.8
2.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
84
1.71
1.00
2.1
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
11
184
0.58
0.98
1.3
1.2
—
16.3
—
0
39
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
54
1.89
0.98
2.7
6.3
%
93.6
97.6
—
10
54
(40765089) Chromosome analysis panel - Blood by G-banded
0
30
0.00
0.98
0.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
176
1651
1.37
0.97
11.3
8.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
72
603
1.29
0.96
5.2
5.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
50
398
1.33
0.96
3.3
2.7
mmol/l
2.4
2.4
0.00
42
362
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
32
0.00
0.96
0.0
2.5
—
26.2
—
0
23
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
32
0.00
0.96
0.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
11
62
1.81
0.96
5.0
7.0
mg/l
520.6
454.1
0.15
11
62
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
62
1.81
0.96
1.7
2.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
102
894
1.27
0.94
7.2
5.3
u/l
142.2
136.6
0.22
94
841
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
27
2.25
0.94
8.0
11.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
52
1.76
0.93
1.9
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
79
672
1.28
0.93
3.7
3.6
estimate
0.0
0.0
—
7
110
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
86
1.67
0.93
2.7
2.4
—
—
—
0
0
(3015736) pH of Urine
65
540
1.29
0.92
3.8
3.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
79
676
1.27
0.88
3.6
3.7
estimate
0.0
0.0
—
8
117
(3019060) Gas panel - Arterial blood
6
30
2.03
0.87
9.0
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
30
2.03
0.87
1.2
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
450
1.30
0.87
9.8
10.2
mmol/l
-0.4
1.2
1.25
42
340
(4010399)
15
96
1.60
0.86
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
198
1.41
0.85
1.1
1.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
31
1.96
0.85
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
31
1.96
0.85
7.2
5.2
—
—
—
0
0
(44813793)
6
31
1.96
0.85
1.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
31
1.96
0.85
4.3
6.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
64
536
1.28
0.85
5.3
4.9
e6/l
0.2
0.3
0.43
46
402
(3000093) Morphology [Interpretation] in Blood Narrative
6
32
1.90
0.82
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
32
1.90
0.82
2.8
1.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
55
454
1.28
0.81
14.4
10.4
mmol/l
1.1
0.9
0.14
44
321
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
136
1246
1.25
0.81
3.5
3.3
pmol/l
14.2
14.4
0.29
127
1134
(3044889) 12 lead EKG panel
53
633
0.78
0.80
2.4
2.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
33
1.84
0.79
4.2
2.1
mmol/l
50.0
38.0
—
6
33
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
78
674
1.25
0.79
5.9
5.2
estimate
0.0
0.0
—
7
118
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
55
456
1.28
0.79
14.5
10.4
—
7.4
—
0
14
(3019150) Specific gravity of Urine by Refractometry
43
345
1.31
0.78
2.6
3.1
kg/l
1.0
1.0
2.07
11
62
(40758558) Short blood count panel - Blood
75
647
1.24
0.77
7.7
10.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
69
796
0.80
0.77
13.5
6.8
ml/min/173m2
109.9
112.3
0.27
45
487
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
34
1.78
0.77
3.0
3.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
211
1.38
0.76
1.4
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
53
1.73
0.76
1.3
3.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
67
1.68
0.76
1.4
2.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
54
1.69
0.75
20.7
11.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
24
2.11
0.75
8.4
6.8
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
24
2.11
0.75
8.4
6.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
24
2.11
0.75
2.4
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
110
0.53
0.74
1.7
3.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
158
0.61
0.74
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
158
0.61
0.74
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
56
1.63
0.73
6.1
7.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
25
2.02
0.73
1.4
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
423
1.27
0.73
2.6
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
81
914
0.82
0.72
2.0
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
146
0.60
0.72
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
40
1.77
0.72
1.4
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
23
170
1.39
0.71
1.8
2.4
g/l
1.0
1.0
0.03
23
162
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
41
1.73
0.70
2.9
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
27
1.87
0.69
1.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
27
1.87
0.69
2.4
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
48
400
1.26
0.66
2.4
2.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
63
542
1.23
0.66
5.1
4.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
29
1.74
0.64
8.2
5.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
105
0.56
0.63
1.5
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
49
412
1.24
0.63
4.9
3.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
32
255
1.30
0.62
5.0
6.3
mg/l
9.2
1.8
0.53
21
186
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
20
0.00
0.60
0.0
2.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
211
1.32
0.60
1.3
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
27
211
1.32
0.60
1.3
1.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
52
1.56
0.60
1.3
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
66
576
1.21
0.60
5.2
5.0
e6/l
27.5
23.9
0.07
48
440
(42870588) Differential panel, method unspecified - Blood
96
868
1.19
0.59
8.9
10.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
75
664
1.20
0.58
6.4
5.8
e6/l
27.9
62.7
0.68
49
454
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
54
1.50
0.58
1.1
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
97
881
1.18
0.56
2.7
2.2
mmol/l
5.5
5.3
0.76
90
792
(3044290) Cell count panel - Cerebral spinal fluid
9
59
1.55
0.55
6.0
6.9
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
61
1.49
0.54
1.4
2.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
40
335
1.24
0.53
8.0
4.3
inr
1.1
1.1
—
6
86
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
51
439
1.21
0.53
2.6
3.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
9
63
1.45
0.53
2.7
4.8
%
27.0
26.5
—
9
63
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
144
1.35
0.52
2.7
2.0
u/ml
176.4
175.3
—
8
67
(3013650) Neutrophils [#/volume] in Blood by Automated count
123
1146
1.17
0.51
11.0
11.7
e9/l
3.0
3.3
0.97
100
948
(3027944) Amphetamines [Presence] in Urine
26
209
1.28
0.49
1.3
1.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
7
46
1.54
0.49
10.0
3.1
ug/l
663.4
276.0
—
7
41
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
146
1.33
0.48
2.7
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
76
837
0.86
0.48
1.8
1.9
u/ml
1.3
3.6
1.17
12
144
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
49
425
1.20
0.47
9.5
9.7
mmol/l
22.8
23.6
1.19
49
413
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
120
1.36
0.47
1.2
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
21
263
0.78
0.47
2.1
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
165
1.30
0.47
1.3
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
156
1.31
0.47
1.3
2.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
117
1092
1.16
0.46
8.1
10.1
e9/l
0.6
0.6
0.09
97
898
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
37
314
1.21
0.45
1.9
1.4
pmol/l
99.2
96.1
0.12
26
160
(3022217) INR in Platelet poor plasma by Coagulation assay
7
51
1.38
0.44
3.1
8.7
—
1.1
—
0
7
(3019230) Fractional oxyhemoglobin in Venous blood
7
51
1.38
0.44
12.7
11.6
%
73.9
71.9
—
7
51
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.0
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
32
1.57
0.42
3.0
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
27
223
1.24
0.42
2.0
1.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
15
0.00
0.41
0.0
2.9
—
5.6
—
0
15
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
336.1
—
0
15
(3041806) Other cells [#/volume] in Blood by Manual count
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
4.9
—
0
15
(3041672) Baker's yeast Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
17
0.00
0.41
0.0
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
101
0.68
0.40
1.9
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
262
1.21
0.39
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
66
1.38
0.39
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
66
1.38
0.39
1.0
1.3
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
9
67
1.36
0.38
2.7
4.8
%
69.7
66.3
—
9
67
(3002523) Influenza virus A Ag [Presence] in Specimen
9
67
1.36
0.38
1.0
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
36
1.40
0.38
2.4
4.0
umol/l
508.8
420.6
—
5
36
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
68
1.34
0.38
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
146
1395
1.15
0.37
4.2
3.6
mu/l
2.0
2.0
0.39
140
1307
(3006245) CD3-CD19+ cells/100 cells in Blood
10
72
1.41
0.37
2.8
4.9
%
13.2
18.2
—
10
72
(3031040) Bacteria [#/volume] in Urine by Automated count
102
953
1.13
0.37
4.5
4.0
—
76.1
—
0
13
(3006315) Basophils [#/volume] in Blood
116
1093
1.13
0.37
8.2
10.1
e9/l
0.0
0.0
0.14
97
898
(3034770) Mitochondria Ab [Titer] in Serum
6
41
1.48
0.36
1.2
2.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
6
41
1.48
0.36
1.3
2.9
—
54.3
—
0
7
(3007853) Bacteria identified in Skin by Aerobe culture
29
247
1.20
0.35
3.1
1.9
—
—
—
0
0
(3000492) Spirometry study
13
100
1.32
0.34
1.8
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
183
1781
1.19
0.34
3.9
3.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
118
1117
1.12
0.34
8.1
10.0
e9/l
2.5
2.4
0.41
103
949
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
6
46
1.31
0.33
4.2
2.8
ug/l
17.1
7.3
—
6
35
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
74
1.37
0.33
1.5
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
74
1.37
0.33
4.6
2.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
47
1.28
0.32
2.5
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
117
1109
1.12
0.32
9.6
10.9
e9/l
0.2
0.2
0.56
101
938
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
53
1.33
0.31
1.4
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
174
1691
1.15
0.30
15.0
11.6
mg/l
23.3
24.2
0.14
121
1140
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
56
1.26
0.29
1.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
56
1.26
0.29
3.9
2.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
55
501
1.13
0.29
16.5
13.7
mmol/l
24.5
24.7
0.25
55
501
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
2.1
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
196
1924
1.22
0.28
22.9
16.7
e9/l
283.1
274.8
0.81
188
1826
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
8
63
1.28
0.28
14.2
14.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
22
187
1.20
0.27
7.0
3.7
ng/l
712.0
1093.9
—
10
114
(3019832) Treponema pallidum Ab [Presence] in Serum
21
245
0.84
0.27
1.8
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
273
1.16
0.26
2.2
1.8
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
72
0.69
0.26
1.2
1.1
—
3.8
—
0
10
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
74
0.67
0.26
1.0
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
9
72
1.26
0.26
1.6
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
9
72
1.26
0.26
12.3
14.8
%
90.1
95.3
—
9
72
(40768797) Stomach Pathology biopsy report
15
123
1.23
0.26
1.8
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
303
1.14
0.25
2.0
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
60
555
1.11
0.25
1.9
2.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
196
1927
1.20
0.25
22.8
16.6
e12/l
4.6
4.6
0.01
188
1820
(3010813) Leukocytes [#/volume] in Blood
196
1928
1.20
0.24
22.8
16.7
e9/l
6.8
6.9
0.41
188
1822
(3009214) Lutropin [Units/volume] in Serum or Plasma
19
162
1.19
0.23
2.1
2.6
u/l
5.8
5.4
0.12
12
105
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
134
1.21
0.23
2.1
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
2.4
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
124
0.80
0.22
2.3
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
10
0.00
0.21
0.0
2.3
—
3.8
—
0
10
(3030313) Adrenal Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.2
—
360.3
—
0
6
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
15
126
1.20
0.21
1.3
1.4
pmol/l
630.3
58261321.1
0.50
15
115
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
27
302
0.88
0.21
2.0
2.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
12
0.00
0.21
0.0
5.2
—
4.5
—
0
12
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
12
144
0.82
0.20
1.7
2.6
iu/l
4.4
7.0
—
7
91
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
14
0.00
0.20
0.0
5.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
28
309
0.89
0.18
1.7
1.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
35
381
0.90
0.18
4.2
3.8
e6/l
6.6
8.3
0.34
35
335
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
82
1.23
0.17
1.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
82
1.23
0.17
1.3
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
68
1.18
0.17
2.8
4.8
—
—
—
0
0
(3013512) EKG study
15
172
0.86
0.16
3.1
2.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
88
0.79
0.15
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
89
0.78
0.15
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
103
1.17
0.14
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
106
0.84
0.13
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
53
503
1.07
0.13
1.8
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
21
191
1.11
0.12
4.3
2.6
ng/l
31.6
19.0
—
5
68
(36660697) Celiac disease serology panel - Serum
38
357
1.08
0.12
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
25
231
1.09
0.11
1.9
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
40
421
0.94
0.10
2.0
2.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
20
184
1.09
0.09
1.2
1.2
u/ml
0.4
1.0
0.81
13
142
(3024980) IgG subclass 4 [Mass/volume] in Serum
6
53
1.13
0.09
1.5
1.7
g/l
1.1
0.6
—
6
48
(3035933) Granulocytes/100 leukocytes in Blood
6
56
1.07
0.08
1.7
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
61
0.81
0.08
2.4
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
185
1.09
0.08
1.2
1.2
u/ml
10.6
7.0
0.26
14
145
(3052851) Hemolysis interference index of Serum or Plasma
7
66
1.06
0.08
6.4
3.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
68
1.03
0.08
1.7
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
6
74
0.80
0.07
4.0
1.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
74
1.08
0.07
13.1
14.4
%
0.8
0.7
—
8
74
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
83
0.84
0.07
1.7
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
57
552
1.04
0.07
6.2
4.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
15
139
1.08
0.05
4.8
2.8
u/l
30.3
33.6
—
10
108
(3009542) Hematocrit [Volume Fraction] of Blood
175
1760
0.96
0.04
22.0
15.1
%
38.7
38.9
0.27
157
1573
(3026008) Bacteria identified in Urine by Culture
39
400
0.97
0.03
3.4
2.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
35
341
1.03
0.02
5.0
5.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
93
1.08
0.02
1.8
2.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
78
786
0.99
0.01
1.8
1.8
g/l
1.3
1.5
0.70
39
390
(3029937) Albumin [Presence] in Urine by Test strip
32
326
0.98
0.01
2.8
3.9
estimate
0.0
0.0
—
8
114
(3021387) Prolactin [Units/volume] in Serum or Plasma
12
114
1.05
0.00
1.4
1.5
mu/l
280.6
363.6
0.60
12
109
(3003327) Ova and parasites identified in Stool by Light microscopy
12
114
1.05
0.00
2.1
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
99
983
1.01
0.00
5.3
4.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
168
1.01
0.00
1.8
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
111
0.99
0.00
1.3
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
32
315
1.02
0.00
2.2
3.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
197
1.02
0.00
1.3
1.3
u/ml
2.0
3.6
0.41
14
136
(3013826) Glucose [Moles/volume] in Serum or Plasma
87
867
1.00
0.00
12.3
7.6
mmol/l
6.4
6.1
0.63
82
815
(3021589) Normoblasts [#/volume] in Blood
104
1036
1.01
0.00
8.8
11.6
e9/l
0.0
0.0
0.47
82
773
(3013707) Erythrocyte sedimentation rate by Westergren method
106
1054
1.01
0.00
4.2
4.7
mm/h
8.8
7.3
0.51
100
982
(3048689) Calprotectin [Mass/mass] in Stool
39
391
1.00
0.00
2.0
3.6
ug/g
39.7
71.1
2.78
33
312
(3042936) Bacteria identified in Isolate by Culture
17
166
1.03
0.00
5.6
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
117
1.03
0.00
2.0
2.1
—
14.6
—
0
5
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
6
60
1.00
0.00
2.0
2.3
nmol/l
0.2
0.1
—
6
51
(3045414) Leukocytes [Presence] in Urine
5
50
1.00
0.00
4.4
1.7
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
5
0.00
0.00
0.0
4.0
—
13.6
—
0
5
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
9
0.00
0.00
0.0
1.4
—
33.2
—
0
9
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
94
0.95
0.00
1.4
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
6
0.00
0.00
0.0
3.5
—
0.3
—
0
6
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
7.8
6.3
ug/l
1.4
2.1
—
5
49
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
26.5
—
25.8
—
0
6
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
6
64
0.93
0.00
3.2
3.8
—
87.4
—
0
17
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
25.8
—
0
8
(3035285) Chloride [Moles/volume] in Venous blood
0
9
0.00
0.00
0.0
2.4
—
107.0
—
0
9
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
9.9
—
0
8
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
2.2
—
1.3
—
0
6
(3012441) Differential panel - Pleural fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.1
—
0.5
—
0
7
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
761.6
—
0
5
(3032641) Amino acids panel - Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
52
0.96
0.00
1.0
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
69
0.86
0.00
1.3
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
77
0.91
0.00
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
5.6
—
138.7
—
0
7
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
6
0.00
0.00
0.0
1.5
—
1.6
—
0
6
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.0
—
305.0
—
0
5
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
6
0.00
0.00
0.0
26.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
11.4
—
47.1
—
0
8
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
52
0.96
0.00
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
1.2
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_BACTERIAL_SEPSIS_NEWBO and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_BACTERIAL_SEPSIS_NEWBO | 1.309 [1.03, 1.66] | 0.027 |
| Birth year | 0.988 [0.98, 1.0] | 0.013 |
During the follow-up period (1.1.1998 — 31.12.2019), 75 out of 15045 males with P16_BACTERIAL_SEPSIS_NEWBO died.
Mortality risk
Mortality risk for people of age
years, who have P16_BACTERIAL_SEPSIS_NEWBO.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.274% |
| 5 | No data | 1.604% |
| 10 | No data | 3.955% |
| 15 | No data | 7.652% |
| 20 | No data | 12.738% |
Relationships between endpoints
↥Index endpoint: P16_BACTERIAL_SEPSIS_NEWBO – Bacterial sepsis of newborn
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data